APA

Gerber D. E., Socinski M. A., Neal J. W., Wakelee H. A., Shirai K., Sequist L. V., Rosovsky R. P., Lilenbaum R. C., Bastos B. R., Huang C., Johnson M. L., Hesketh P. J., Subramaniam D. S., Dietrich M. F., Chai F., Wang Y., Kazakin J., Schwartz B., Schiller J. H., Brahmer J. R. & Kelly R. J. (20190408). Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. : Lung cancer (Amsterdam, Netherlands).

Chicago

Gerber David E, Socinski Mark A, Neal Joel W, Wakelee Heather A, Shirai Keisuke, Sequist Lecia V, Rosovsky Rachel P, Lilenbaum Rogerio C, Bastos Bruno R, Huang Chao, Johnson Melissa L, Hesketh Paul J, Subramaniam Deepa S, Dietrich Martin F, Chai Feng, Wang Yunxia, Kazakin Julia, Schwartz Brian, Schiller Joan H, Brahmer Julie R and Kelly Ronan J. 20190408. Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. : Lung cancer (Amsterdam, Netherlands).

Harvard

Gerber D. E., Socinski M. A., Neal J. W., Wakelee H. A., Shirai K., Sequist L. V., Rosovsky R. P., Lilenbaum R. C., Bastos B. R., Huang C., Johnson M. L., Hesketh P. J., Subramaniam D. S., Dietrich M. F., Chai F., Wang Y., Kazakin J., Schwartz B., Schiller J. H., Brahmer J. R. and Kelly R. J. (20190408). Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. : Lung cancer (Amsterdam, Netherlands).

MLA

Gerber David E, Socinski Mark A, Neal Joel W, Wakelee Heather A, Shirai Keisuke, Sequist Lecia V, Rosovsky Rachel P, Lilenbaum Rogerio C, Bastos Bruno R, Huang Chao, Johnson Melissa L, Hesketh Paul J, Subramaniam Deepa S, Dietrich Martin F, Chai Feng, Wang Yunxia, Kazakin Julia, Schwartz Brian, Schiller Joan H, Brahmer Julie R and Kelly Ronan J. Randomized phase 2 study of tivantinib plus erlotinib versus single-agent chemotherapy in previously treated KRAS mutant advanced non-small cell lung cancer. : Lung cancer (Amsterdam, Netherlands). 20190408.